Trial of Ruxolitinib in COVID-19 Complications Fails: Novartis
News: Latest | Digests | Channels | Categories | Gallery
Posted on: December 15, 2020
Category: News , Infectious Diseases
Trial of Ruxolitinib in COVID-19 Complications Fails: Novartis
Novartis said a late-stage clinical trial of ruxolitinib on top of standard therapy showed no significant reduction in severe complications of COVID-19, including death, respiratory failure requiring mechanical ventilation or admission to the intensive care unit.
Reuters Health Information
Welcome to the healthcare-only HIPAA - GDPR compliant cloud. Exclusively hosted on a HPC environment!
Learn more or start today by choosing your secure HIPAA - GDPR compliant server's Operating System bellow and pick the package that's best for you.
BIPmd makes it simple to launch in the cloud and scale up as you grow – whether you’re running one virtual machine, thousand or more.
Looking for a custom solution?
Our technicians can provide you with the best custom-made solutionss on the market, no matter whether you're a small business or large enterprise.
Get in touch